<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Saccon E</submitter><funding>Vetenskapsrådet (VR)</funding><funding>Vetenskapsrådet</funding><funding>Karolinska Institutet</funding><funding>University of Missouri (MU)</funding><funding>Karolinska Institutet (KI)</funding><funding>University of Missouri</funding><pagination>e0054921</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8565516</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(2)</volume><pubmed_abstract>In one year of the coronavirus disease 2019 (COVID-19) pandemic, many studies have described the different metabolic changes occurring in COVID-19 patients, linking these alterations to the disease severity. However, a complete metabolic signature of the most severe cases, especially those with a fatal outcome, is still missing. Our study retrospectively analyzes the metabolome profiles of 75 COVID-19 patients with moderate and severe symptoms admitted to Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (Lombardy Region, Italy) following SARS-CoV-2 infection between March and April 2020. Italy was the first Western country to experience COVID-19, and the Lombardy Region was the epicenter of the Italian COVID-19 pandemic. This cohort shows a higher mortality rate compared to others</pubmed_abstract><journal>Microbiology spectrum</journal><pubmed_title>Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy.</pubmed_title><pmcid>PMC8565516</pmcid><funding_grant_id>2017-01330</funding_grant_id><funding_grant_id>2020-01554</funding_grant_id><pubmed_authors>Blasi F</pubmed_authors><pubmed_authors>Aliberti S</pubmed_authors><pubmed_authors>De Roberto P</pubmed_authors><pubmed_authors>Costantino G</pubmed_authors><pubmed_authors>Lorson CL</pubmed_authors><pubmed_authors>Neogi U</pubmed_authors><pubmed_authors>Billi F</pubmed_authors><pubmed_authors>Valenti L</pubmed_authors><pubmed_authors>Saccon E</pubmed_authors><pubmed_authors>Gabriel EE</pubmed_authors><pubmed_authors>Peyvandi F</pubmed_authors><pubmed_authors>Sachs MC</pubmed_authors><pubmed_authors>Bandera A</pubmed_authors><pubmed_authors>Krishnan S</pubmed_authors><pubmed_authors>Baldini L</pubmed_authors><pubmed_authors>Scudeller L</pubmed_authors><pubmed_authors>Singh K</pubmed_authors><pubmed_authors>Lashari AA</pubmed_authors><pubmed_authors>Canetta C</pubmed_authors><pubmed_authors>Fracchiolla NS</pubmed_authors><pubmed_authors>Gori A</pubmed_authors><pubmed_authors>Sciume M</pubmed_authors><pubmed_authors>COVID-19 Network Working Group,</pubmed_authors><pubmed_authors>Mikaeloff F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy.</name><description>In one year of the coronavirus disease 2019 (COVID-19) pandemic, many studies have described the different metabolic changes occurring in COVID-19 patients, linking these alterations to the disease severity. However, a complete metabolic signature of the most severe cases, especially those with a fatal outcome, is still missing. Our study retrospectively analyzes the metabolome profiles of 75 COVID-19 patients with moderate and severe symptoms admitted to Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (Lombardy Region, Italy) following SARS-CoV-2 infection between March and April 2020. Italy was the first Western country to experience COVID-19, and the Lombardy Region was the epicenter of the Italian COVID-19 pandemic. This cohort shows a higher mortality rate compared to others</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-06-01T01:59:02.602Z</modification><creation>2025-06-01T01:59:02.602Z</creation></dates><accession>S-EPMC8565516</accession><cross_references><pubmed>34468185</pubmed><doi>10.1128/Spectrum.00549-21</doi></cross_references></HashMap>